Soft Tissue Engineering Biotechnology Company Sofregen Raises $8 Million in Series B Funding Round
Jonathan Hartmann joins company as new Chief Executive Officer; Healthcare industry veteran Philippe Schaison joins Board of Directors BOSTON, Dec. 17, 2019 /PRNewswire/ — Sofregen Medical, Inc. (Sofregen), an early stage medical device company, announced today that it has raised $8 million in new funding. The company is developing an advanced platform of products based […]